Vol 8, No 4 (August 13, 2017): Journal of Gastrointestinal Oncology

Original Article

A single institute retrospective trial of concurrent chemotherapy with SIR-Spheres® versus SIR-Spheres® alone in chemotherapy-resistant colorectal cancer liver metastases
May Cho, Jonathan Kessler, John J. Park, Aram Lee, Jun Gong, Gagandeep Singh, Yi-Jen Chen, Philip H. G. Ituarte, Marwan Fakih
Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases
Andrew Kennedy, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Adeel Kaiser, Charles W. Nutting, Steven C. Rose, Eric A. Wang, Michael A. Savin
Tumor stage in patients operated for rectal cancer: a comparison of the pre-operative MR and the resection specimen, with specific attention to the effect of neo-adjuvant radiotherapy
Elmer E. van Eeghen, Sandra D. Bakker, Gerwin Fransen, Marcel J. Flens, Ruud J. L. F. Loffeld
Cyclooxygenase-2 gene polymorphisms and susceptibility to colorectal cancer in a Brazilian population
Michele Tatiana Pereira Tomitão, Sergio Carlos Nahas, Marcia Saldanha Kubrusly, Tatiane Katsue Furuya, Marcio Augusto Diniz, Suely Kazue Nagahashi Marie, Adriana Vaz Safatle-Ribeiro, José Eluf-Neto, Ivan Cecconello, Ulysses Ribeiro Junior
Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans
Michael D. Baek, Christian S. Jackson, John Lunn, Chris Nguyen, Nicole K. Shah, Steve Serrao, David Juma, Richard M. Strong
Outcomes and complications of radiation therapy in patients with familial adenomatous polyposis
Meng Gan, Dustin Boothe, Deborah W. Neklason, N. Jewel Samadder, Jonathan Frandsen, Megan B. Keener, Shane Lloyd
The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis
Croix C. Fossum, Jasim Y. Alabbad, Lindsay B. Romak, Christopher L. Hallemeier, Michael G. Haddock, Marianne Huebner, Eric J. Dozois, David W. Larson
Epidemiological profile of gastric cancer in the northwestern region of Algeria: about 116 cases
Safia Fehim, Racheda Bouhaous, Mustapha Diaf, Amine Mokhtar Drici, Meghit Boumediene Khaled
Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma
Pamela J. Boimel, Abigail T. Berman, Jonathan Li, Smith Apisarnthanarax, Stefan Both, Kristi Lelionis, Gary L. Larson, Ursina Teitelbaum, John N. Lukens, Edgar Ben-Josef, James M. Metz, John P. Plastaras
Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors
Matthew L Knecht, Ning Wang, April Vassantachart, Rachel Mifflin, Jerry D Slater, Gary Y Yang
The role of induction chemotherapy + chemoradiotherapy in localised pancreatic cancer: initial experience in Scotland
Derek Grose, David McIntosh, Nigel Jamieson, Ross Carter, Euan Dickson, David Chang, Husam Marashi, Christina Wilson, Mohammed Alfayez, Ashleigh Kerr, Roisin O’Donoghue, Lea Haskins, Fraser Duthie, Colin J. McKay, Janet Graham
A margin distance analysis of the impact of adjuvant chemoradiation on survival after pancreatoduodenectomy for pancreatic adenocarcinoma
Lee M. Ocuin, Jennifer L. Miller-Ocuin, Mazen S. Zenati, John A. Vargo, Aatur D. Singhi, Steven A. Burton, Nathan Bahary, Melissa E. Hogg, Herbert J. Zeh III, Amer H. Zureikat
Feasibility and reproducibility of substituting oral contrast with water for duodenal volume delineation in patients undergoing pancreatic stereotactic body radiotherapy
Guangyin Wu, Vivek Verma, Matthias F. Haefner, Sicong Li, Chi Lin
Utilization and trends in palliative therapy for stage IV pancreatic adenocarcinoma patients: a U.S. population-based study
Audrey S. Kulaylat, Katelin A. Mirkin, Christopher S. Hollenbeak, Joyce Wong
Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?
Irene Giacomelli, Daniele Scartoni, Homan Mohammadi, William F. Regine, Michael D. Chuong
Gemcitabine and capecitabine for advanced biliary cancer
Emmanuel Gabriel, Shipra Gandhi, Kristopher Attwood, Boris Kuvshinoff, Steven Hochwald, Renuka Iyer
Splenectomy is an independent risk factor for poorer perioperative outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an analysis of 936 procedures
Akshat Saxena, Winston Liauw, David L. Morris

Review Article

Primary pancreatic lymphoma: what we need to know
Neda Rad, Alireza Khafaf, Amir Houshang Mohammad Alizadeh